 | Up a level |
Landi, Antonio; Wlodarczak, Adrian; Tölg, Ralph; Kelbæk, Henning; Legutko, Jacek; Galli, Stefano; Godin, Matthieu; Toth, Gabor G; Lhermusier, Thibault; Honton, Benjamin; Dietrich, Peter Laurenz; Stammen, Francis; Ferdinande, Bert; Silvain, Johanne; Capodanno, Davide; Cayla, Guillaume; Valgimigli, Marco (2023). Design and Rationale of the BIOFLOW-DAPT Trial: a Prospective, Randomized, Multicenter Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination with 1-Month Dual Antiplatelet Therapy. Journal of cardiovascular translational research, 16(5), pp. 1135-1143. Springer 10.1007/s12265-023-10400-x
Cassese, Salvatore; Kufner, Sebastian; Xhepa, Erion; Byrne, Robert A; Kreutzer, Johanna; Ibrahim, Tareq; Tiroch, Klaus; Valgimigli, Marco; Tölg, Ralph; Fusaro, Massimiliano; Schunkert, Heribert; Laugwitz, Karl-Ludwig; Mehilli, Julinda; Kastrati, Adnan (2016). Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Clinical research in cardiology, 105(7), pp. 575-584. Springer-Medizin-Verlag 10.1007/s00392-015-0953-x
Sherif, Mohammad A; Abdel-Wahab, Mohamed; Awad, Omar; Geist, Volker; El-Shahed, Ghada; Semmler, Reinhard; Tawfik, Mazen; Khattab, Ahmed A; Richardt, Doreen; Richardt, Gert; Tölg, Ralph (2010). Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation. American Heart Journal, 160(5), pp. 862-9. St. Louis, Mo.: Elsevier 10.1016/j.ahj.2010.07.017
Liska, Branislav; Khattab, Ahmed A; Herrmann, Lutz; Abdel-Wahab, Mohamed; Westphal, Ronja; Tölg, Ralph; Geist, Volker; Richardt, Gert (2008). Simvastatin and ezetimibe in addition to nonpharmacological risk factor modification for achieving new low-density lipoprotein cholesterol targets. Herz, 33(5), pp. 362-7. München: Springer-Medizin-Verlag 10.1007/s00059-008-3084-6
